What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer? Souhil LebdaiVictor BassetFrançois Audenet Invited Review 15 September 2015 Pages: 617 - 624
Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia Souhil LebdaiNicolas Barry DelongchampsRomain Mathieu Invited Review 15 August 2015 Pages: 625 - 632
Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7 Friedemann ZengerlingAnca AzoiteiMarcus V. Cronauer Original Article 29 August 2015 Pages: 633 - 639
HAROW: the first comprehensive prospective observational study comparing treatment options in localized prostate cancer Lothar WeissbachSteffen StuerzebecherDietrich Schnell Original Article 15 September 2015 Pages: 641 - 647
Multiparametric MRI of the prostate at 3 T: limited value of 3D 1H-MR spectroscopy as a fourth parameter Stephan H. PolanecKatja Pinker-DomenigPascal A. Baltzer Original Article 25 September 2015 Pages: 649 - 656
The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients W. van den BosD. M. de BruinJ. J. M. C. H. de la Rosette Original Article Open access 22 August 2015 Pages: 657 - 664
Quality assessment in prostate cancer centers certified by the German Cancer Society Christoph KowalskiJulia FerenczSimone Wesselmann Original Article 21 September 2015 Pages: 665 - 672
Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study Raphaële Renard-PennaMorgan RoupretPierre Mozer Original Article 24 September 2015 Pages: 673 - 678
Clinical evaluation and technical features of three-dimensional laparoscopic partial nephrectomy with selective segmental artery clamping Yuan RuanXiao-hai WangDong-liang Xu Original Article 29 August 2015 Pages: 679 - 685
Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery Rodrigo A. LedezmaEdris NegronScott E. Eggener Original Article 25 September 2015 Pages: 687 - 693
Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy Kamran Zargar-ShoshtariHomayoun ZargarPhilippe E. Spiess Original Article 19 August 2015 Pages: 695 - 701
Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study T. GrimmA. BuchnerA. Karl Original Article 16 September 2015 Pages: 703 - 708
Epithelial–mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma Johannes BreyerMichael GierthWolfgang Otto Original Article 22 September 2015 Pages: 709 - 716
The hydrodynamic basis of the vacuum cleaner effect in continuous-flow PCNL instruments: an empiric approach and mathematical model R. MagerC. BalzereitD. Schilling Original Article 10 September 2015 Pages: 717 - 724
Evaluation of renal function in patients with a main renal stone larger than 1 cm and perioperative renal functional change in minimally invasive renal stone surgery: a prospective, observational study Songzhe PiaoJuhyun ParkSung Yong Cho Original Article 31 July 2015 Pages: 725 - 732
Is there a place for virtual reality simulators in assessment of competency in percutaneous renal access? Yasser A. NoureldinNader FahmySero Andonian Original Article 05 August 2015 Pages: 733 - 739
Simulation of RIRS in soft cadavers: a novel training model by the Cadaveric Research On Endourology Training (CRET) Study Group Emre HuriAndreas SkolarikosCesare Marco Scoffone Original Article 30 August 2015 Pages: 741 - 746
Pharmacological modulation of ureteric peristalsis in a chronically instrumented conscious pig model: effect of adrenergic and nitrergic modulation H. RoshaniS. WeltingsW. H. Lamers Original Article 15 August 2015 Pages: 747 - 754
Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity Benoit PeyronnetMathieu RoumiguiéXavier Gamé Original Article 18 August 2015 Pages: 755 - 761
Comment on: “Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years” Christoph-A. von KlotAxel S. Merseburger Letter to the Editor 24 September 2015 Pages: 763 - 764